The present invention provides compositions of matter, kits and methods for their use in the treatment of MAP kinase-related conditions and/or HMG-CoA reductase-related conditions. In particular, the invention provides compositions for treating inflammatory and/or cardiovascular conditions in an animal subject by inhibiting p38.alpha. MAP kinase and/or HMG-CoA reductase, as well as providing formulations and modes of administering such compositions. The invention further provides methods for the rational design of inhibitors of MAP kinase, HMG-CoA reductase, or both for use in the practice of the present invention.

 
Web www.patentalert.com

< 7-azaindoles as inhibitors of c-jun n-terminal kinases for the treatment of neurodegenerative disorders

< Method for treating myolytic disease and method for screening antimyolytic agent

> Small molecule inhibitors of rotamase enzyme activity

> Naphthyl benzoxazoles and benzisoxazoles as estrogenic agents

~ 00225